•'
`
`I DATA FOR
`BIOCHEMICAL
`RESEARCH
`
`EDITED BY
`
`R. M. C. DAWSON
`DAPHNE C. ELLIOTT
`W. H. ELLIOTT
`K. M. JONES
`
`OXFORD
`AT THE CLARENDON PRESS
`1959
`
`Petitioner - Catalent Pharma Solutions
`Ex. 1023, Pg. 1 of 6
`
`

`

`Oxford University Press, Amen House, London E.C.4
`GLASGOW NEW YORK TORONTO MELDOURNE WELLINGTON
`
`DOr-.lDAY CALCUTIA MADRAS KARACHI KUALA LUMPUR
`
`CAPE TOWN IDADAN NAIRDDI ACCRA
`
`© Oxford University Press I959
`
`PRINTED IN GREAT BRITAIN
`
`Petitioner - Catalent Pharma Solutions
`Ex. 1023, Pg. 2 of 6
`
`

`

`CONTENTS
`
`CONTRIBUTORS
`
`NOTES ON THE USE OF THIS BOOK
`
`ABBREVIATIONS
`
`I. TABLE OF BIOCHEMICAL COMPOUNDS
`1. Amino acids, peptides, and related nitrogenous compounds
`2. Carboxylic acids, alcohols, aldehydes, and ketones
`3. Phosphate esters, including nucleotides
`4. Purines, pyrimidines, and nucleosides
`5. Spectral data and pK values for purines, pyrimidines, nucleosides,
`and nucleotides
`6. Carbohydrates and related compounds
`7. Lipids and fatty acids
`8. Steroids
`9. Fat soluble vitamins
`10. Water soluble vitamins
`11. Porphyrins and related compounds
`12. Chlorophylls and their derivatives
`13. Carotenoids
`14. Enzyme inhibitors
`15. Metal chelating agents
`16. Aptimetabolites
`17. 'Drugs and other pharmacologically active compounds
`18. Miscellaneous compounds
`19. Macromolecules
`
`II. ENZYMES COMMONLY USED AS LABORATORY
`'REAGENTS'
`
`III. BUFFERS AND PHYSIOLOGICAL MEDIA
`
`IV. METHODS FOR THE DETECTION OF BIOCHEMICAL
`COMPOUNDS ON PAPER
`
`ix
`
`xi
`
`xiii
`
`2
`28
`44
`66
`
`74
`80
`100
`110
`120
`122
`128
`138
`144
`148
`154
`156
`160
`172
`174
`
`178
`
`192
`
`210
`
`V. THE PROPERTIES OF SOME ION EXCHANGE RESINS 273
`
`VI. ISOTOPIC DATA
`
`VII. MANOMETRY
`
`VIII. NOMOGRAMS FOR MANOMETER CONSTANTS
`
`IX. AMMONIUM SULPHATE SOLUTIONS
`
`274
`
`277
`
`279
`
`281
`
`X. MISCELLANEOUS REAGENTS, TESTS, AND RECIPES 283
`vii
`
`Petitioner - Catalent Pharma Solutions
`Ex. 1023, Pg. 3 of 6
`
`

`

`CONTENTS
`XI. ACID-BASE INDICATORS
`
`XII. TABLE OF NORMALITIES
`
`XIII. AUTOCLAVES: TEMPERATURE-PRESSURE CONVER(cid:173)
`SION TABLE
`
`XIV. MISCELLANEOUS FORMULAE
`
`XV. INTERNATIONAL ATOMIC WEIGHTS, 1955
`
`INDEX
`
`288
`
`289
`
`289
`
`289
`
`290
`
`291
`
`viii
`
`Petitioner - Catalent Pharma Solutions
`Ex. 1023, Pg. 4 of 6
`
`

`

`
`
`
`
`.62:.u:cuEa:afiEimiuuz
`
`fiat—:3...“Ho:2.
`
`8.333555...flES.—:3:an
`
`A3035?.3—$9
`
`
`
`.552...>33.5?$33!:—3%
`
`
`
`.OES3:923—E26ca:
`
`
`
`
`
`En.m:,Ufifiuum.EmCuE
`
`iEamN55$
`
`Amway
`
`
`
`.vamC9.4».mm
`
`inE::53EbEsflw.95:
` $2..va.mminaRE:Em.Nmin.N33:
`
`
`
`«co..32533S3.35.
`
`:nm:in£15.!
`
`
`
`.3..32EOEEEO
`
`:3:
`
`£52mF.9:325
`an:inamin._
`
`
`
`35...>252:52.,.55.N:2:=2.5.<2:
`
`
`
`.5:F.O":wows;
`
`.3
`
`3::E.m.Vfié
`
`
`
`anti—OFF.OuzaAuOn—fiuvcu
`
`.uméEsp.
`
`
`
`32.:as.am4.:._
`
`
`
`mmZOHmMQZ<.mMQWIqu/x
`
`:25:;.S.2:2:
`
`3.:.E5E:.35.,_
`
`55:a.fis:M£3:
`55:m..N.=aU{Eh.30
`.3EOEx:on"O“:E
`
`3%:E._.=_G.5:.u
`3:“:EOEion:2
`
`55...._02:.m
`
`manJ.==u.S=,®.30
`
`
`
`Qua:3mm.E55
`
`vaC:m.m:Ufifi
`:3fin._i=3.~_O:O
`:3:itEOE,05.v.
`
`:555:“4.9m.0":s
`
`mEuznm#2...”th
`
`
`
`
`
`.Efiuufiuu...E.Omfl:.uccu.53
`
`i=8".3552:fl2532
`£3:E.m:06.5.nG2:2%.8in
`
`
`
`:2:
`
`
`
`mEuu5.5£225....Em.N33:a5.mm4.:
`
`33:3c.3fin._
`
`mm
`
`
`
`33....23;£259»Em.,N:3:Ea:3Se
`
`
`
`
`
`
`
`isa.
`on:,m
`:3
`min—
`
`our-emvn
`mgrN.wfi
`.—
`20:3
`~N'm
`nmé
`Nmé
`nmé
`
`
`:Eu2.93:.5E:8it..0:is.233
`
`:25NN
`
`
`
`
`
`...=9u2$
`
`
`:3;.9:2a.:.53
`
`
`
`
`
`:05.m”on:3.2..amm
`
`.5“ion.8no":E
`
`
`
`5;ion..05s
`
`:0i6.:8
`
`
`
`"52.2..23...22.
`
`355..55233..,0":
`
`
`ENESOONismi»::<
`
`a:EE:E_EEr.
`
`..5:0
`
`.5".:O«Wnu”0.:ON
`
`
`
`:Oi.m,_m”on:.m
`
`:33{EN.23”
`3:83Eiscm.0“:
`{an.12£3.125
`
`ammoEE:E_§E
`
`
`
`.:O_m.mHof2.2..53¢
`
`
`
`:OE.m,2”on:.w
`
`
`
`.59EOE.10":.mfi
`
`
`Amiga52%E.isan:EOE
`
`2%”on:2.3m2w:
`
`
`
`EunumEu.335"5..m<
`
`
`yum—Kb:
`
`ce—.5
`EEE
`
`
`
`
`
`.7:93::—
`
`5:5
`
`.1ENmay—Eu—
`
`Ca:Eat
`
`nDZIE::6:
`
`E51:
`
`.5flucafl
`
`.uu<A§V.55.c...EEEG—BE
`
`AIS—ED.mm.92.BEE£50;
`
`.EE.35....“$1.:7..52
`
`gum52E.53E2:535550
`.3.”6:03:43KEEPS—.56nN
`E3136mumacro;men.3.5uEn.m
`
`.=o:n~:o=ua.2:.>353523‘
`Eon:.3mficcEm.53”EuEEm
`
`
`EEEEHE31332:.555:«ism
`
`:52...:3u==5=u353:.53.u<
`.Ecu.u:u~E=2_?2Ea£En:“n
`
`:5:DJ.“F.2533SEEuEmzcm
`
`mumug—Hub”..534:“do:EOE
`.E.92£05:5:3.3”:
`.a=cE2:16mm>53::m:c::=
`
`1:55:59.3532:.E258Egun—=23uh...$2538HP
`
`
`
`mE—EEm.3.6EVE.EON:334
` 2;:
`.Eu:nth—SLED"GE:
`
`
`SEES:EESUE..:E:.:,HEEESNERéigiu.
`
`
`
`
`
`
`.aUFO:22.:m2;:5£51.60:3ICE,m”on:3a.:
`.mRS:2J..EZN.m55.:5.;,5:0.5.._
`8%:«an.m.a6:.
`$2,3.526.EQ._
`2nJ,sci.E35»
`
`".32”3.3..uEEEEm..N93:a3.mm4.:
`
`3;:E..m:.3:
`
`#0?.MNAthfiU<E=T
`2::pm.m:U
`3::E.3.i:._
`
`32.:PM.m...55._
`
`2mm:Ev.3—.UHE.
`
`$.vaemv.mm<12A:5:
`4:".._;_O.u.>WO":8
`Emiu<m
`
` .mAOEOOJ4“mnloaxUHAVXOmmde‘D.N.H@1339
`
`
`
`
`
`..R3.32.232
`
`
`
`2.3L.(c3‘53:32..
`
`
`
`
`
`
`
`3mmi.332:NON—
`
`3:60:
`
`
`
`
`
`..I.530.232.31
`
`
`
`
`
`3m::,E.._8ES
`
`
`
`
`336:mm.3~
`
`
`
`..Zgmbu.6:6:59»:
`
`.5355
`
`
`
`RS.E..602.3.
`
`
`
`
`
`
`
` 2..fish.26:a5
`
`
`
`SEEagmm..I.5mficufl.352:
`
`
`
`
`
`2.:5.1.Eons—E:3:2.:
`
`::a»:2.0:
`
`Ocean
`
`
`..1Ear....253:
`0"»:+2.3;
`
`E8Eu:
`
`0“:
`
`
`
`
`
`no”3g.525._cuEa:
`
`
`
`
`
`”Ein:us..mcucom.EETEEE
`
`Pnennml:02.6:
`
`
`
`In:AHEOENTNS
`
`an;
`
`
`
`w0U.~OEU/MIU
`
`:OOUAIDVUNEDOULED
`$000LEW
`
`\Eu
`\HEU
`{:u
`
`“SEESG.
`umgxafinu
`352:3
`96.625qu
`Umu0_fl>:=
`4.33.:
`u=u_.:=n.muw
`SEA..Nu_
`£23...
`inn—SEND
`.2352
`2.56:
`32.393
`6.5%HN”_.axohgié
`£2558
`£9.35:
`E:
`~buu<
`235::
`2:
`Batu
`.235:
`:EEEA
`#555:
`:EnEm
`Bus
`1:32...
`3:
`ES
`a:
`ES
`
`Eonusua—
`AU.Euu
`:3“.gm.r.2
`Eun9.35.:5
`ERu_Eu<2
`.5r!.I2
`.ocfiaménw«N
`“2:1:
`3—5nz.llan
`u:Buu<Z
`.25:F!3
`$25.33.S3:.
`8:533
`a:
`:5My!ON
`"6.3
`
`
`EDOU.U.»IU.UOO:
`
`Inm.000:
`
`O0.0.E0.000_._
`
`E:
`
`fuiozuiomugzu
`
`
`
`Oinioou:10
`
`uZOOU$3.0
`
`:ODU.Jag
`
`95..:O.50,Eu
`
`:oou."IO.Eu.":0
`
`
`
`On:$05.8,an.
`
`.056.az
`
`
`
`"aid.uz
`
`
`
`:OOU.um—U.nIU.EU
`
`04550de
`
`aim.fioidv.nu
`
`
`
`:OOU.5:“:"EU
`
`Peti ioner - Catalent Pharma Solutions
`Ex. 1023, Pg. 5 of6
`
`
`
`dfl.523m;Egan—n
`
`
`
`
`
`NE4...:.5.”d:._32.:
`
`5;:m26255is3.2;
`:OOU.“:0A«:04:0.uIU.UOOE
`
`2A:E.E.“:5
`
`JpuUDOU.DU..:U.00LED
`
`
`..023:32...532.9:
`:OOU.0:fi_:000O:5000:
`
`
`
`::omIV.7:.3»:62
`
`m:2.a:2.:
`
`
`
`..:.3:
`
`New3m2$35:49..E2:
`
`as:::Ea:25E.E52
`
`
`
`i§<EEKEutéi.2.<<
`
`SiEck
`
`mEflUOOUAZU.00$30
`
`«:0.IOEU.DU.NEU
`
`
`
` “ED.OD‘:OOO.:OO.EU
`
`”EU.OU."ID
`
`.OEuuZEN
`.33am.Eu:
`uzuuuofiue.m
`
`22:252
`
`.23<.ifiE
`
`EDOU,OU;=U,OUAIU
`
`.9854uNum>zkmn3uu<.2
`
`Petitioner - Catalent Pharma Solutions
`Ex. 1023, Pg. 5 of 6
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`

`

`.55Emma—no
`
`
`
`
`
`.3wanna—Euinmum.diva—OE.3353:.—con—351.62:0
`
`
`
`
`
`_.55::m.R
`
`
`
`£23.59Eu.”BERT:mu.2353ruin—ES.ESEEEuEi
`
`
`
`
`
`23:32.25Eusna2::Euuxu
`
`
`
`
`
`
`
`
`
`
`
`m=Em=a=Lmmumsn
`
`2:323...»m<.m
`
`mmZOHmMQz<.mmmwmmmq<
`
`
`
`
`
`
`
`
`mmmm
`
`
`
`
`
`.u1com—En:E::cznhcuucuuAhwml
`.EE:.6:mwm:5:.6333am.
`mEmauEE5;?.EEEucEEEmuuanJc.5.—m<.n0W”m
`
`.mEumsnazzuugu«Enmum—Eh.nh.m.|u
`
`
`.ut.52552::ctEEuuzcuarmmN...)
`uEEEuuccuFEE1:5mum—“Eucm:xv
`953:...55,2353.5.Eamu
`
`
`1:...=atEEuucounon:21315:.92:.WU...“Sufi.hvM+V?..JUNE
`
`
`
`
`
`
`
`:65:na>in335:2»::8:.1.055,;I.:0my.:.355E3:5...2:92:Ea:EEEEm:S.nEFLfists:5.:a::3“5:2..S.m..m333:313:O~:~.=N..AOOU.:D:U;:UU:3=N.Iz:
`
`5215315233».83:25.54:.Nwe.3:35.30
`.DESEEEuuEnFanF.On:Gnu...E4
`
`
`
`EEEéEH«miniwzfimruAnna:..23.“;:...255.
`ianusfizfifloszmEEO.—.fi
`
`
`
`engaginfiuceufig53:2:32.:E..«E.3:.m.....2a.m:w.:«..E...“23.:
`.EcfiEEfiEEndiamAIOWEuE
`
`
`
`356E;cazndzfimiu.E33>?II0.:2.6m..2:ESE:OJE;O“=.U§ZI:2ml.1.
`
`
`
`
`€535.53352:5...72:533.33595:._:..=u.m.:o_u0.:Za;._2:sN9:3.13::52+2:oou;:u.mo:u.uco:.133.32.;E:EEEO
`
`
`
`
`
`€531.58enciozn§=flao32.Enigma“?3.331%,3:£06:920.:f,:2::a.315F593:22232.22:zoouazufiozudoo:..
`
`
`
`
`.E.3E82:22:En:“335m,S.n.32;5.33.5ofa;:34.25..:8,..:5=N.!885565:5._mu=5:22?:0.5.=N«Aoou.mozu..=9
`
`
`3232.535«cw—Eouznmfi..:#8ca.9:a:.3:.an_,.E.550SEE:onzmauxoouiomuamu.::55.i3
`.233...5.:5_u33:an
`33.332va;423::Hz.Ea:ENE.
`E05:3v.322+a.a“3:ME:33...,m<aa::.new“52%.,..:"as.3...2:
`
`E.3:.5:3:33.38:,u:N82.:m:.2:.33.£3:....:can2::anu
`
`
`
`
`
`.92.2556»;SEEQEEDéUNEEVSMKEv.2:._amevaame—Ud.‘.;s.:o.m.o.:a:3.1:Eumanmwfiw—a5:e:co:u/EUnunwmvwnhwx
`
`
`
`
`
`
`
`
`
`
`2:8Ea:has:n.5953::0Eur.232...:.5.“2E.m.EELfisica.5".EOE..2:EN5E:E?>moém:OOUiOIUAEUHEEEEmEu...2.23...E:
`
`
`
`
`.92.ESEE;:EiEEE...HN:mmcmfiéi6,5.._233%.5—3:..._,222123...::ooudu3.5595950Asian:flaky—eamm
`.EowaflEEnmhunzm.E
`
`
`
`
`25°.—55.35:n:o955::0Euu”502...:ham43.m.EEL£2595.Eu.IOE0.:S..hm.Ecrfi«no.mN:3:Smoém:OOU.IOEU.HEUEZEELHun2.0.55.3
`
`
`
`
`92555133.235=54HN:3:2.1:;v.1:4a:.n.56.555ED.Eu,m.74:30.:.52-2:4::2.3.:oou.ou;:u;=u.uoo=39.5.0...vagawwflémm
`.3.»53a:522.may._EOE.::...333.933
`
`
`
`
`
`
`
`
`
`”1::didcsgxszcaa323215059;Emiéz.325.3”.:_£a_u_._u:_:.ma:7m.7:EuruflfiwécmuEEwWWL:e::ooudu;:u;:u.£o
`ESEE3:55.E.:E:.:uu:EEEnELactiifi.s3.nfii::tciuufibaS:.2SSEckESE—Sm.£52
`
`
`
`
`.352.:afi.53.3.:..on:.mh..:5J.1a22.is“.5,3%308596.45
`
`
`
`
`
`
`
`
`:n3:2:A:.95.,_:,3,”0.::3.:3.a:._z:2.ES3...3...::oou..:u.:omu,uoo:gamma»:ehflwa2:
`
`
`
`
`::3:Swim—0.5.4t:35.057m3EEK3..._E:To:25:::25c:“3.21.5Eu:2222d::OOUEUNIUOOOI
`
`
`..0325,:....:25.:
`
`
`
`
`:::.m,_m.io.:z_3_if..cm.3452.BEE:0;:.=Nnnoou.:ozug:uv:535.!am
`
`.Ea:E.53:.._....3.:ice6.:e.:EE2:55;:5858539.5fixu.mmm.~gammy:a
`
`.125:SS.5..:.._=.€_u:ofi.ofl:.m.>:2..mE.3548:5:Escudo—64:”.::3E.1.E.
`
`
`
`
`
`
`
`
`.I.EEUurn:$55,:.5EOE.m.14,.Os:.m..mmwin2mafia.396»:"Em.300U.lOIUQIU..:3J.|.mm
`...2:.3§22.:..:mvamv:WEE.Efiw
`
`
`£5132...9;:..Evnu—Wow.Eanm...”haw“.
`
`.32:.5:2.550_
`
`e2:2:“5.man.3:.mEn.;it.526.:moou..\..._.
`
`223:5:utEEEE:é,\
`
`
`:2::2.mmin.n32.:,
`52:3.2:,3:.N.69,m.3EOEcan.n......Eas.
`
`:3:23.mmin5.6.-e:..a.
`33::mm3..5545”
`a:d_
`“.22..Si...3..mEm:EU2%Eu5.
`.
`”ES23753.N:3:on:..
`...i
`.3.32in:
`:3:a:.fi.52.:.,_cg6%..:$2:
`:33m7>.utuun.m.
`H.5..a5.9.E,..,:._..._.._..fi_.h
`.....
`EB.
`.
`
`.:ofi.::...mbu.E.R,R~
`..636:,.
`
`....
`
`
`,._.,::.v:.232
`
`
`
`
`,352%
`
`_,Aoum3.29Euu.
`5“:Em...565
` {‘illllllllllllllll
`5.:
`...
`..
`8.:
`z
`.»
`
`
` .mQHU<UHAVNOmM/wu.N.Hmum/Nd.
`
`5d3:
`EAra—En
`
`
`
`
`
`
`
`
`
`
`
`
`a:
`
`
`52
`
`Peti ioner - Catalent Pharma Solutions
`Ex. 1023, Pg. 6 of6
`
`Petitioner - Catalent Pharma Solutions
`Ex. 1023, Pg. 6 of 6
`
`
`
`
`
`